Genetic Testing in Clinical Settings

被引:40
作者
Franceschini, Nora [1 ]
Frick, Amber [2 ]
Kopp, Jeffrey B. [3 ]
机构
[1] Univ N Carolina, Gillings Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27516 USA
[2] Univ N Carolina, UNC Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27516 USA
[3] NIDDK, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA
关键词
IMPLEMENTATION CONSORTIUM GUIDELINES; DOMINANT POLYCYSTIC KIDNEY; STEVENS-JOHNSON-SYNDROME; HLA-B GENOTYPE; HYPERSENSITIVITY SYNDROME; COST-EFFECTIVENESS; GENOMIC MEDICINE; AMERICAN-COLLEGE; INDUCED MYOPATHY; CPIC GUIDELINES;
D O I
10.1053/j.ajkd.2018.02.351
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Genetic testing is used for screening, diagnosis, and prognosis of diseases consistent with a genetic cause and to guide drug therapy to improve drug efficacy and avoid adverse effects (pharmacogenomics). This In Practice review aims to inform about DNA-related genetic test availability, interpretation, and recommended clinical actions based on results using evidence from clinical guidelines, when available. We discuss challenges that limit the widespread use of genetic information in the clinical care setting, including a small number of actionable genetic variants with strong evidence of clinical validity and utility, and the need for improving the health literacy of health care providers and the public, including for direct-to-consumer tests. Ethical, legal, and social issues and incidental findings also need to be addressed. Because our understanding of genetic factors associated with disease and drug response is rapidly increasing and new genetic tests are being developed that could be adopted by clinicians in the short term, we also provide extensive resources for information and education on genetic testing.
引用
收藏
页码:569 / 581
页数:13
相关论文
共 80 条
[21]  
Howard HC, 2011, PHARMACOGENOMICS, V12, P1367, DOI [10.2217/PGS.11.100, 10.2217/pgs.11.100]
[22]   Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility [J].
Hughes, A. R. ;
Spreen, W. R. ;
Mosteller, M. ;
Warren, L. L. ;
Lai, E. H. ;
Brothers, C. H. ;
Cox, C. ;
Nelsen, A. J. ;
Hughes, S. ;
Thorborn, D. E. ;
Stancil, B. ;
Hetherington, S. V. ;
Burns, D. K. ;
Roses, A. D. .
PHARMACOGENOMICS JOURNAL, 2008, 8 (06) :365-374
[23]   Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity [J].
Hughes, DA ;
Vilar, FJ ;
Ward, CC ;
Alfirevic, A ;
Park, BK ;
Pirmohamed, M .
PHARMACOGENETICS, 2004, 14 (06) :335-342
[24]   Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms [J].
Hung, CC ;
Lin, CJ ;
Chen, CC ;
Chang, CJ ;
Liou, HH .
THERAPEUTIC DRUG MONITORING, 2004, 26 (05) :534-540
[25]  
Hung CC, 2012, PHARMACOGENOMICS, V13, P1339, DOI [10.2217/PGS.12.117, 10.2217/pgs.12.117]
[26]   HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol [J].
Hung, SL ;
Chung, WH ;
Liou, LB ;
Chu, CC ;
Lin, M ;
Huang, HP ;
Lin, YL ;
Lan, JL ;
Yang, LC ;
Hong, HS ;
Chen, MJ ;
Lai, PC ;
Wu, MS ;
Chu, CY ;
Wang, KH ;
Chen, CH ;
Fann, CSJ ;
Wu, JY ;
Chen, YT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (11) :4134-4139
[27]   Pharmaco genetics: an opportunity for a safer and more efficient pharmacotherapy [J].
Ingelman-Sundberg, M .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (03) :186-200
[28]   Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update [J].
Johnson, J. A. ;
Caudle, K. E. ;
Gong, L. ;
Whirl-Carrillo, M. ;
Stein, C. M. ;
Scott, S. A. ;
Lee, M. T. ;
Gage, B. F. ;
Kimmel, S. E. ;
Perera, M. A. ;
Anderson, J. L. ;
Pirmohamed, M. ;
Klein, T. E. ;
Limdi, N. A. ;
Cavallari, L. H. ;
Wadelius, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) :397-404
[29]   Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics [J].
Kalia, Sarah S. ;
Adelman, Kathy ;
Bale, Sherri J. ;
Chung, Wendy K. ;
Eng, Christine ;
Evans, James P. ;
Herman, Gail E. ;
Hufnagel, Sophia B. ;
Klein, Teri E. ;
Korf, Bruce R. ;
McKelvey, Kent D. ;
Ormond, Kelly E. ;
Richards, C. Sue ;
Vlangos, Christopher N. ;
Watson, Michael ;
Martin, Christa L. ;
Miller, David T. .
GENETICS IN MEDICINE, 2017, 19 (02) :249-255
[30]   Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans [J].
Kang, Hye-Ryun ;
Jee, Young Koo ;
Kim, Yon-Soo ;
Lee, Chang Hwa ;
Jung, Jae-Woo ;
Kim, Sae Hoon ;
Park, Heung-Woo ;
Chang, Yoon-Seok ;
Jang, In-Jin ;
Cho, Sang-Heon ;
Min, Kyung-Up ;
Kim, Sang-Heon ;
Lee, Kyung Wha .
PHARMACOGENETICS AND GENOMICS, 2011, 21 (05) :303-307